AFP and neoplasm: Non-germinomatous GCTs often secrete tumour markers such as alpha-fetoprotein (AFP) or beta-human chorionic gonadotropin (β-HCG) and typically require multimodal therapy due to relative resistance to single-modality treatment [4].